Fc epsilon receptor

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 23.01.2021

Dieser Artikel auf Deutsch

Synonym(s)

Fc epsilon receptor; Fcε-R

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The Fc epsilon receptor (Fcε receptor - see below Fc receptor) binds the Fc domain of free IgE. Fcε-receptors are found on the surface of mast cells and basophilic granulocytes. Binding of antigens to these bound antibodies results in activation of the respective cell. The IgE/Fc-RI interaction is followed by antigenic cross-linking of receptors at the plasma membrane level. The chains of Fc-RI do not aggregate without antigen contact. This is possibly prevented as a consequence of the extensive glycosylation of the front and back sides of the molecule.

These processes play a crucial role in type I allergy.

In mammals, two types of Fcε receptors are distinguished,

  • FcεRI, receptors with high affinity to IgE.
  • and
  • FcεRII, receptors with low affinity to IgE.

The high-affinity IgE receptor (FcεRI) can bind monomeric IgE. The low-affinity IgE receptor FcεRII(CD23) interacts preferentially with IgE complexes.

General informationThis section has been translated automatically.

Fc epsilon receptor I

High affinity Fc epsilon receptor I (FcεRI) is produced by eosinophil granulocytes mast cells and basophil granulocytes, but also by monocytes/macrophages and dendritic cells. The Fc epsilon receptor I is involved in allergic reactions and in the defense against parasitic infections.

The FcεRI on mast cells and basophilic granulocytes consists of an alpha and beta chain as well as 2 gamma chains. In contrast, monocytes/macrophages, eosinophilic granulocytes and dendritic cells produce trimeric receptors consisting of one alpha and 2 beta chains.

IgE binding occurs through the alpha chain of the receptor. FcεRI does not bind immunoglobulins other than IgE. A receptor can bind one monomeric IgE molecule at a time. Its affinity for IgE is very high. The half-life of receptor binding to IgE is several days. After that, the IgE molecule is released again and is available for re-binding. On mast cells, binding to FcεRI leads, among other things, to an increase in FcεRI expression.

Under physiological conditions, a mast cell expresses between several thousand and one million high-affinity IgE receptors. However, degranulation of the mast cell does not occur by simple binding. This occurs only by cross-linking of at least 2 FcεRI. Here, the strength of mast cell degranulation depends on the number of cross-linked FcεRI.

IgE-induced activation and degranulation does not usually cause the death of mast cells. Thus, mast cells can survive multiple cycles of de- and regranulation. After IgE-induced degranulation of the mast cell, a refractory phase occurs. In the skin, this refractory phase, during which the mast cell can show no, or only a very weakened immune response, lasts only a few days. Afterwards it is fully functional again. The beta-chain and the gamma-chains of the FcεRI have functions in the signal transduction after the IgE activation of the receptor.

Fc epsilon receptor II (FcεR II).

Most low-affinity Fc epsilon receptors (FcεR II) are expressed by B lymphocytes. FcεR II has multiple functions as a membrane-bound or even soluble receptor. Fc epsilon Receptor II controls the growth and differentiation of B cells. Furthermore, FcεR II blocks IgE binding of eosinophils, monocytes and basophils.

Authors

Last updated on: 23.01.2021